1. RELEVANCE OF FURTHER CLINICAL TRIALS OF THE USE OF MELATONIN IN ADJUVANT CANCER THERAPY
   Е. Р. Smorodin, 2021, Russian Journal of Biotherapy CrossRef
2. Role and dynamics of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in burn patients
   Adina Stanciu et al, 2021, Experimental and Therapeutic Medicine CrossRef
3. Reconstructive challenges of sinonasal tumors: A case report
   Dragos Palade et al, 2022, Experimental and Therapeutic Medicine CrossRef
4. TNF-α May Exert Different Antitumor Effects in Response to Radioactive Iodine Therapy in Papillary Thyroid Cancer with/without Autoimmune Thyroiditis
   Dan Cristian Gheorghe et al, 2021, Cancers CrossRef
5. Nasopharyngeal carcinoma: A new synthesis of literature data (Review)
   Daniela Jicman (Stan) et al, 2021, Experimental and Therapeutic Medicine CrossRef
6. Decreased Circulating Melatonin with Loss of Age-Related Biphasic Change in Patients with Oral Squamous Cell Carcinoma
   Yu-Fen Tsai et al, 2021, Journal of Personalized Medicine CrossRef
7. Experimental Study on the Influence of Apigenin K and Melatonin in Socket Preservation as Bone Stimulators: An Experimental Study in Beagle Dogs
   José Luis Calvo-Guirado et al, 2020, Applied Sciences CrossRef
8. Melatonin: Emerging Player in the Management of Oral Cancer
   Sagar Dholariya et al, 2023, Critical Reviews™ in Oncogenesis CrossRef
9. Clinical significance of serum matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in the first phase of burn trauma evolution
   Adina Stanciu et al, 2021, Experimental and Therapeutic Medicine CrossRef